Log in
Enquire now
Vertex Pharmaceuticals

Vertex Pharmaceuticals

Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders.

OverviewStructured DataIssuesContributors

Contents

global.vrtx.com
vertexpharm.com
vrtx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
0
Tissue engineering
Tissue engineering
Genomics
Genomics
‌
Genome editing
Regenerative medicine
Regenerative medicine
...
Location
Coralville, Iowa
Coralville, Iowa
San Diego
San Diego
Boston
Boston
0
Cambridge, Massachusetts
Cambridge, Massachusetts
United States
United States
United Kingdom
United Kingdom
Canada
Canada
B2X
B2B
B2B
CEO
Reshma Kewalramani
Reshma Kewalramani
Founder
‌
Kevin Kinsella
‌
Joshua Boger
AngelList URL
angel.co/vertex-pha...ceuticals-1
Legal Name
Vertex Pharmaceuticals Incorporated0
Legal classification
Public company
Public company
0
Number of Employees (Ranges)
1,001 – 5,0000
Email Address
investorinfo@vrtx.com0
mediainfo@vrtx.com0
Phone Number
+161734161000
Number of Employees
4,1470
Full Address
50 NORTHERN AVE BOSTON, MA 02210 UNITED STATES0
CIK Number
875,320
Place of Incorporation
Massachusetts
Massachusetts
DUNS Number
602478257
IRS Number
43,039,129
Founded Date
1989
0
Competitors
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Stock Symbol
VRTX
Exchange
Nasdaq
Nasdaq
0
CFO
‌
Charles (Charlie) Wagner
0
Key People
David Altshuler
David Altshuler
‌
Stuart A. Arbuckle
‌
Michael J. Parini
‌
Amit K. Sachdev
Reshma Kewalramani
Reshma Kewalramani
Jeffrey Leiden
Jeffrey Leiden
Patents Assigned (Count)
812
COO
‌
Stuart A. Arbuckle
0
Wellfound ID
vertex-pharmaceuticals-1
Technologies Used
CRISPR
CRISPR
CRISPR-Cas9
CRISPR-Cas9
Country
United States
United States
Headquarters
Cambridge, Massachusetts
Cambridge, Massachusetts

Other attributes

Company Operating Status
Active
Invested in
Obsidian Therapeutics
Obsidian Therapeutics
Arbor Biotechnologies
Arbor Biotechnologies
CRISPR Therapeutics
CRISPR Therapeutics
Arbor Biotechnologies
Arbor Biotechnologies
SIC Code
2,834
Ticker Symbol
VRTX0
Wikidata ID
Q2744099

Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders. Vertex’s product Trikafta was approved by the USFDA in 2019 for treatment of cystic fibrosis. Other approved cystic fibrosis medicines from Vertex include Symdeko, Orkambi and Kalydeco.

Vertex and CRISPR Therapeutics are collaborating with their treatment, CTX001, made from a patient’s own stem cells harvested and edited using CRISPR technology to increase fetal hemoglobin levels to treat transfusion-dependent beta thalassemia and sickle cell disease.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Boston-Based Vertex Aims to Tackle Sickle Cell Disease, Inspire Students

https://www.nbcboston.com/news/local/boston-based-vertex-aims-to-tackle-sickle-cell-disease-inspire-students/2974137

Web

February 15, 2023

Could Vertex's cystic fibrosis medicines hold a clue to treating deadly pneumonia?

Jason Mast

https://www.statnews.com/2022/12/07/vertex-cystic-fibrosis-medicines-treatment-for-pneumonia-ards/

Web

December 7, 2022

ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing - Immunogen (NASDAQ:IMGN)

Vandana Singh

https://www.benzinga.com/general/biotech/23/03/31126063/immunogen-allows-vertex-pharma-use-its-technology-for-conditioning-agents-for-use-with-gene-editi

Web

ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen's ADC Technology in the Development of Novel Targeted Conditioning Agents

https://www.businesswire.com/news/home/20230301005166/en/ImmunoGen-Announces-a-Global-Multi-Target-License-and-Option-Agreement-with-Vertex-for-the-Use-of-ImmunoGens-ADC-Technology-in-the-Development-of-Novel-Targeted-Conditioning-Agents

Web

March 1, 2023

Prioritizing Personal & Professional Development

https://youtu.be/LaL6KZJKpeg

Web

January 26, 2022

References

Find more companies like Vertex Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.